Annals of Medicine
Volume 54, 2022 - Issue 1
Open access
2,838
Views
4
CrossRef citations to date
0
Altmetric
Oncology
Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy
Christoph Minichsdorfera Department of Medicine I & CCC, Division of Oncology, Medical University of Vienna, Wien, Austria
, Andreas Gleissb Medical University of Vienna, Center for Medical Statistics, Informatics, and Intelligent Systems Institute of Clinical Biometrics, Wien, Austria
, Marie-Bernadette Aretinc Pharmacy Department, Vienna General Hospital – Medical University Campus, Wien, Austria
, Manuela Schmidingerd Department of Urology, Medical University of Vienna, Wien, Austria
& Thorsten Fueredera Department of Medicine I & CCC, Division of Oncology, Medical University of Vienna, Wien, AustriaCorrespondence[email protected]
Pages 1339-1349
|
Received 16 Sep 2021, Accepted 21 Apr 2022, Published online: 10 May 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.